Liver Fibrosis

Five marker index yields fibrosis clues in hepatitis C patients

Published in Hepatitis Weekly, May 6th, 2002

by Sonia Nichols, senior medical writer - Physicians who have their chronic hepatitis C patients tested for as few as five serum markers might learn more about how the patients are responding to therapy for their disease.

That's what a multicenter team of investigators in France said in a new report of a fibrosis index they developed and evaluated in a retrospective study of more than 150 patients infected with hepatitis C virus (HCV) who had been randomized to receive standard or more aggressive IFN therapy.

"One-hundred sixty-five patients who had had two interpretable liver biopsies and at least one stored serum sample before IFN treatment were...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-05-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry